Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mehrad Hamedani is active.

Publication


Featured researches published by Mehrad Hamedani.


Journal of Proteomics | 2018

Thyroid-associated orbitopathy and tears: A proteomics study

Edina Kishazi; Marianne Dor; Simone Eperon; Aurélie Obéric; Mehrad Hamedani; Natacha Turck

To date, Thyroid-Associated Orbitopathy (TAO), an autoimmune inflammatory disease affecting the eye, remains poorly characterised and its diagnosis challenging. The aim of this study was to investigate the tears of the TAO patients in order to identify potential biomarkers. Two independent quantitative Tandem Mass Tag™ 6-plex experiments were done. After in-solution digestion and isoelectric fractionation, the 12 fractions were analysed with a LTQ Orbitrap Velos coupled to a liquid chromatography. Raw files were searched against Swiss-Prot-AC database using Proteome Discoverer software, with a false discovery rate of 1% at peptide and protein levels. The differential proteins were then verified using orthogonal approaches in independent patients. Globally, 712 tear proteins were quantified with 2 unique peptides. Interestingly, cystatin c (TAO/controls ratio: 1.53), alpha-1 antichymotrypsin (ratio: 1.70) and retinal dehydrogenase (ratio: 0.68), displaying differential levels in the tears of TAO patients using proteomics experiments emerged as highly promising biomarkers after verification. In conclusion, this proteomics study supports the idea that tears reflect biological modifications occurring in a disease context and can therefore be a promising fluid for biomarker discovery. Moreover, our study identified three candidates that could in the future open new avenues in the diagnosis of TAO disease. SIGNIFICANCE Thyroid associated orbitopathy (TAO) is the most common disease affecting the orbit. Moreover, the later, severe stages of the disease can be sight threating [1]. On the other hand, the early sign and symptoms can be mistaken with other ocular pathologies [2]. Here we explore the modification of the tear content of the TAO patients using proteomics strategies and we proposed three new biomarker candidates, which could allow the early diagnosis of the disease and prompt action to prevent more severe stages. Moreover, our findings could also help to better understand the pathophysiology of the disease.


Klinische Monatsblatter Fur Augenheilkunde | 2012

Clinical manifestations of mucous membrane pemphigoid in a tertiary center.

E. Mameletzi; Mehrad Hamedani; François Majo; Yan Guex-Crosier

Mucous membrane pemphigoid (MMP) is a progressive inflammatory disease of autoimmune etiology. We performed a retrospective analysis of clinical signs and treatment on 16 patients. Conjunctival biopsies were performed in all patients and showed typical immuno-deposits at the basement membrane zone. The mean age at presentation was 69 years, 60 % were female.12 patients demonstrated ocular involvement (11 bilaterally). At the time of referral to our hospital, 92 % had reached an advanced stage III or IV. All patients presented conjunctival fibrosis with resultant fornix foreshortening. Trichiasis and symblepharon were found in 11 patients. Keratitis was found in 11 patients resulting in ulceration in 5 cases. Complications required surgical interventions included: entropion surgery (n = 2), tarsorrhaphy (n = 1), amniotic membrane transplantation (n = 2), keratoplasty (n = 1). Systemic immunomodulatory therapy is the treatment of choice. Dapsone (n = 8), steroids (n = 8), azathioprine (n = 5), cyclophosphamide (n = 2), mycophenolate mofetil (n = 4) and methotrexate (n = 1) were used concomitantly or consecutively. Early diagnosis can prevent ocular complications. Immunomodulatory therapy has provided an avenue for preserving vision. The management of MMP requires a multidisciplinary approach.


Klinische Monatsblatter Fur Augenheilkunde | 2015

Different locations of dermoid cysts in the orbital region.

Y. Sadeghi; Aurélie Obéric; Mehrad Hamedani

BACKGROUND Dermoid cysts are frequent unilateral congenital benign tumors that can be found at different locations throughout the body. In the orbital region, dermoid cysts occur predominantly in the supero-temporal quadrant. However, different orbital locations are possible, making this entity an important differential diagnosis for orbital tumors. PATIENTS AND METHODS We retrospectively reviewed the charts of 23 consecutive patients operated in our institution between 2005 and 2014 for orbital tumors that were diagnosed as congenital dermoid or epidermoid cysts. RESULTS There were 21 dermoid and 2 epidermoid cysts. The median age at surgery time was 7 years (range 1-41). There were 15 females and 8 males. Eleven cysts were located supero-temporally (47.8%), seven supero-medially (30.4%), two temporally (8.7%), one at the frontal bone (4.4%) and two in the fossa of the lacrimal gland (8.7%). The mean cyst diameter was 13.1 mm±5.0 (SD). None had signs of malignant disease. No recurrence was observed after complete excision. CONCLUSION Dermoid cysts of orbital region are mostly located in the supero-temporal quadrant. However, other orbital locations are possible and dermoid cysts must thus be considered in the differential diagnosis of any mass in the orbital region.


Scientific Reports | 2018

Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy

Edina Kishazi; Marianne Dor; Simone Eperon; Aurélie Obéric; Natacha Turck; Mehrad Hamedani

The aim was to investigate the levels of cytokines and soluble IL-6R in the tears of patients with thyroid-associated orbitopathy (TAO) disease. Schirmer’s test was adopted to collect tears from TAO patients (N = 20, 17 women, mean age (±SD): 46.0 years (±13.4)) and healthy subjects (N = 18, 10 women, 45.4 years (±18.7)). Lacrimal cytokines and soluble IL-6R (sIL-6R) were measured using a 10-plex panel (Meso Scale Discovery Company) and Invitrogen Human sIL-6R Elisa kit, respectively. Tear levels of IL-10, IL-12p70, IL-13, IL-6 and TNF-α appeared significantly higher in TAO patients than in healthy subjects. Interestingly, IL-10, IL-12p70 and IL-8 levels increased in tears whatever the form of TAO whereas IL-13, IL-6 and TNF-α levels were significantly elevated in inflammatory TAO patients, meaning with a clinical score activity (CAS) ≥ 3, compared to controls. Furthermore, only 3 cytokines were strongly positively correlated with CAS (IL-13 Spearman coeff. r: 0.703, p = 0.0005; IL-6 r: 0.553, p = 0.011; IL-8 r: 0.618, p = 0.004, respectively). Finally, tobacco use disturbed the levels of several cytokines, especially in patient suffering of TAO. The differential profile of lacrimal cytokines could be useful for the diagnosis of TAO patients. Nevertheless, the tobacco use of these patients should be taken into account in the interpretation of the cytokine levels.


Experimental Eye Research | 2018

Investigation of the global protein content from healthy human tears

Marianne Dor; Simone Eperon; Patrice H. Lalive; Yan Guex-Crosier; Mehrad Hamedani; Cindy Salvisberg; Natacha Turck

ABSTRACT Considering absence of invasiveness and side effects, tears emerge as a particularly attractive fluid for biomarker discovery and therefore for daily clinical use. However, to date this fluid remains poorly studied in healthy condition. Here, we present an updated in‐depth characterisation of the human healthy tear protein composition using proteomics approach. Both eyes of 8 healthy controls (4 men and 4 women, average age: 38 ± 18) were collected using the Schirmers strip method. After liquid digestion and off‐gel electrophoresis fractionation, three independent proteomics analyses were performed on a LTQ‐Orbitrap Velos Pro. Globally, 1351 proteins were identified with 2 unique peptides and 1% FDR. Gene ontology analyses showed up that 39% of the tear proteins were enzymes, with high numbers of dehydrogenases, phosphatases, kinases and ligases. Immunoglobulins, serpins and 14‐3‐3 domains proteins also emerged as the main tear protein families. The glycolysis and the coagulation and complement cascades, which were already shown in tears as involved in ocular and systemic diseases, were highlighted performing pathway analyses. Our study therefore complements the existing data on healthy tears proteome. Nevertheless, extensive studies for deeply and definitively characterise this promising fluid are required in the near future in order to be able to routinely use this fluid in clinics. A better understanding of its protein content will probably open new avenues in the biomarker discovery and clinical practice in the near future. Graphical abstract Summary of the experimental workflow followed in this study. GPF: gas‐phase fractionation mode; LTQ: linear trap quadrupole; IPG: immobilized pH gradient. DAVID: Database for Annotation, Visualization and Integrated Discovery; STRING: Search Tool for the Retrieval of Interacting Genes/Proteins; KEGG: Kyoto Encyclopedia of Genes and Genomes. Figure. No Caption available. HighlightsTear fluid contains a high variety of proteins.A lot of enzymes, more precisely hydrolases and transferases, were identified.Pathways involved in different diseases can be greatly mapped in tears.Combination of different studies is essential to establish a reliable tear proteome.


Klinische Monatsblatter Fur Augenheilkunde | 2010

Malignant Transformation of a ”Benign” Lacrimal Gland Tumor

D. Bertschinger; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani

Myoepithelial carcinoma is a very rare epithelial carcinoma occurring usually in the salivary gland. Only about 45 cases have been reported in detail [1]. The lacrimal gland is another, but much rarer, possible tumor site, with only 2 cases reported. Because of its rarity, the clinical behavior is not well understood yet and treatment remains challenging. We describe a case of malignant transformation of a pleomorphic adenoma into a myoepithelial carcinoma.


Survey of Ophthalmology | 2007

Diagnosis and Management of Enophthalmos

Mehrad Hamedani; Jean-Antoine C. Pournaras; David Goldblum


American Journal of Ophthalmology | 2006

Tumors of the Caruncle: A Clinicopathologic Correlation

Pierre-François Kaeser; Sylvie Uffer; Leonidas Zografos; Mehrad Hamedani


Graefes Archive for Clinical and Experimental Ophthalmology | 2015

Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review

Aleksandra Petrovic; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani


Klinische Monatsblatter Fur Augenheilkunde | 2017

Gravesʼ Ophthalmopathy in a Paediatric Population

Y. Sadeghi; Aurélie Obéric; G. Theintz; Mehrad Hamedani

Collaboration


Dive into the Mehrad Hamedani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge